NYSE
CRL
Charles River Laboratories International, Inc.
- Health Care
- Listed 2000
- 1 day
- +1.8%
- 1 month
- +16.1%
- 1 year
- +76.6%
$265.51 · Mkt cap $12.8B
At the 6 Aug 2026 close
NYSE
Charles River Laboratories International, Inc.
$265.51 · Mkt cap $12.8B
At the 6 Aug 2026 close
Charles River Laboratories International, Inc. trades under the ticker CRL on NYSE, in the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch). It has been listed since 2000. Its market capitalisation is $12.8B. The last closing price was $265.51, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +76.6%, and +16.1% over the past month. Returns are price returns and exclude dividends.
This page exists because CRL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.